EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.
REUTERS/Jim Bourg/File Photo
US lawmakers question Mylan's Medicaid EpiPen rebates – Reuters